CM
CM Management’s Lantern Pharma LTRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Hold |
200,000
| – | – | 0.58% | 52 |
|
|
2025
Q1 | $708K | Hold |
200,000
| – | – | 0.71% | 41 |
|
|
2024
Q4 | $638K | Buy |
200,000
+15,000
| +8% | +$47.9K | 0.57% | 47 |
|
|
2024
Q3 | $679K | Buy |
185,000
+105,000
| +131% | +$385K | 0.54% | 52 |
|
|
2024
Q2 | $374K | Buy |
80,000
+15,000
| +23% | +$70.1K | 0.34% | 57 |
|
|
2024
Q1 | $572K | Sell |
65,000
-15,000
| -19% | -$132K | 0.48% | 54 |
|
|
2023
Q4 | $342K | Buy |
80,000
+5,000
| +7% | +$21.4K | 0.28% | 63 |
|
|
2023
Q3 | $256K | Hold |
75,000
| – | – | 0.27% | 60 |
|
|
2023
Q2 | $423K | Buy |
75,000
+15,000
| +25% | +$84.6K | 0.41% | 57 |
|
|
2023
Q1 | $290K | Hold |
60,000
| – | – | 0.34% | 53 |
|
|
2022
Q4 | $362K | Buy |
60,000
+10,000
| +20% | +$60.3K | 0.43% | 54 |
|
|
2022
Q3 | $239K | Buy |
50,000
+4,900
| +11% | +$23.4K | 0.27% | 66 |
|
|
2022
Q2 | $258K | Buy |
45,100
+11,335
| +34% | +$64.8K | 0.27% | 66 |
|
|
2022
Q1 | $241K | Buy |
+33,765
| New | +$241K | 0.2% | 71 |
|
|
2021
Q1 | – | Sell |
-10,000
| Closed | -$193K | – | 92 |
|
|
2020
Q4 | $193K | Buy |
+10,000
| New | +$193K | 0.18% | 77 |
|